NCT05739435Phase 2Active not recruiting

Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis

Study sponsor: Alumis Inc · ALMS

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2027-12-01Estimated
Enrollment · participants165Actual
Source updated2026-07-28Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Primary completion date changed

Before: 1 Dec 2026. After: 1 Dec 2027.

Check registry source

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview